Stock Events

Stock Events

Evoke Pharma 

€0.000000
0
+€0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

People Also Follow

This list is based on the watchlists of people on Stock Events who follow EV0.MU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Astrazeneca
AZN
Mkt Cap302.65B
AstraZeneca has a strong portfolio in gastrointestinal drugs, competing in the same market as Evoke Pharma.
Takeda Pharmaceutical
TAK
Mkt Cap52.99B
Takeda Pharmaceutical Company has a significant presence in gastroenterology, making it a direct competitor.
Abbvie
ABBV
Mkt Cap461.26B
AbbVie has a range of products for gastrointestinal diseases, competing with Evoke's offerings.
Johnson & Johnson
JNJ
Mkt Cap633.19B
Johnson & Johnson, through its pharmaceutical division Janssen, offers medications for gastrointestinal health, competing with Evoke.
Sanofi
SNY
Mkt Cap103.32B
Sanofi has a diversified portfolio that includes treatments for gastrointestinal disorders, making it a competitor.
Pfizer
PFE
Mkt Cap138.61B
Pfizer has a broad range of pharmaceutical products, including treatments for gastrointestinal conditions, competing with Evoke.
Novartis
NVS
Mkt Cap305.1B
Novartis offers several medications for gastrointestinal diseases, directly competing with Evoke Pharma's products.
Merck
MRK
Mkt Cap319.99B
Merck has a presence in the gastrointestinal drug market, making it a competitor to Evoke Pharma.
GSK
GSK
Mkt Cap107.47B
GlaxoSmithKline produces medications for a variety of conditions, including gastrointestinal diseases, competing with Evoke.

About

Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray that has completed Phase 3 clinical trials to treat symptoms associated with acute and recurrent diabetic gastroparesis in females. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California.
Show more...
CEO
Mr. David A. Gonyer
Employees
4
Country
United States
ISIN
US30049G1040

Listings

MU
DE
EV0.MU
STU
DE
EV0.STU

0 Comments

Share your thoughts

FAQ

What is Evoke Pharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange Evoke Pharma stocks are traded under the ticker EV0.MU.
How many employees does Evoke Pharma have?▼
As of July 10, 2026, the company has 4 employees.
In which sector is Evoke Pharma located?▼
Evoke Pharma operates in the Health & Wellness sector.
When did Evoke Pharma complete a stock split?▼
Evoke Pharma has not had any recent stock splits.
Where is Evoke Pharma headquartered?▼
Evoke Pharma is headquartered in Solana Beach, United States.